한빛사논문
- 조회164
Yun Gi Kim MD, PhD a∗, Hyoung Seok Lee MD a∗, Hoseob Kim MPH b, Mina Kim MS b, Joo Hee Jeong MD a, Yun Young Choi MD a, Jaemin Shim MD, PhD a, Jong-Il Choi MD, PhD, MHS, MSc a, Young-Hoon Kim MD, PhD a
aDivision of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Anam Hospital, Seoul, Republic of Korea
bDepartment of Data Science, Hanmi Pharm Co, Ltd, Seoul, Republic of Korea
∗Drs Yun Gi Kim and Hyoung Seok Lee contributed equally to this work.
Address for correspondence: Dr Jong-Il Choi
Abstract
Background: Early rhythm control therapy mainly with antiarrhythmic drugs (AADs) for new-onset atrial fibrillation (AF) reduces major adverse cardiovascular events. However, negative dromotropic effects of AADs via ion channel blocking may cause bradyarrhythmias.
Objectives: This study aimed to evaluate the association between AAD use and the risk of pacemaker implantation or syncope in patients with new-onset AF receiving early rhythm control therapy with AADs.
Methods: This study was based on data from the Korean National Health Insurance Service system. We screened all new-onset AF diagnoses that occurred from 2013 to 2019 and identified patients who were prescribed AADs within 1 year of AF diagnosis. The risk of pacemaker implantation or syncope was compared between AAD users and nonusers.
Results: A total of 770,977 new-onset AF cases were identified and 142,141 patients were prescribed AADs. After multivariate adjustment, use of AADs was associated with 3.5-, 2.0-, and 5.0-fold increased risk of pacemaker implantation or syncope, syncope, and pacemaker implantation, respectively. Propensity score-matched analysis revealed similar results, demonstrating a significant association between AAD use and the risk of pacemaker implantation or syncope. This association was consistent across various subgroups. Women were more susceptible to adverse effects of AADs than men.
Conclusions: This study showed an association between AADs and risk of pacemaker implantation or syncope, a consistent finding across various subgroups. Precise evaluation of such risk should be undertaken before prescription of AADs.
논문정보
- Research article
- 2024년 03월 (BRIC 등록일 2024-03-26)
- 국내 연구진
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
